Evidence map›Paper›PMID 37787993›Full record

Trial reportJAMA network open2023

Ethical Aspects of Physician Decision-Making for Deprescribing Among Older Adults With Dementia.

Jonathan D Norton, Chan Zeng, Elizabeth A Bayliss, Susan M Shetterly, Nicole Williams, Emily Reeve, Matthew K Wynia, Ariel R Green, Melanie L Drace, Kathy S Gleason and 2 more

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in JAMA network open, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Antithrombotic therapy at the end-of-life-continue or stop?Research and practice in thrombosis and haemostasis · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 3 countries.

Jonathan D NortonJohns Hopkins University School of Medicine, Baltimore, Maryland.
Chan ZengInstitute for Health Research, Kaiser Permanente Colorado, Aurora.
Elizabeth A BaylissInstitute for Health Research, Kaiser Permanente Colorado, Aurora.
Susan M ShetterlyInstitute for Health Research, Kaiser Permanente Colorado, Aurora.
Nicole WilliamsJohns Hopkins University School of Medicine, Baltimore, Maryland.
Emily ReeveCentre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Melbourne, Victoria, Australia.
Matthew K WyniaUniversity of Colorado Center for Bioethics and Humanities, Anschutz Medical Campus, Aurora.
Ariel R GreenJohns Hopkins University School of Medicine, Baltimore, Maryland.
Melanie L DraceInstitute for Health Research, Kaiser Permanente Colorado, Aurora.
Kathy S GleasonInstitute for Health Research, Kaiser Permanente Colorado, Aurora.
Orla C SheehanRCSI Hospitals Group, Connolly Hospital, Dublin, Ireland.
Cynthia M BoydJohns Hopkins University School of Medicine, Baltimore, Maryland.
Kaiser Permanente · USJohns Hopkins Medicine · USJohns Hopkins University · USConnolly Hospital Blanchardstown · IEMonash University · AUUniversity of Colorado Anschutz Medical Campus · USUniversity of Colorado Denver · US

Funding

Optimal Medication Management in Alzheimer's Disease and DementiaR33AG057289 · NIA · KAISER FOUNDATION RESEARCH INSTITUTE · PI BAYLISS, ELIZABETH A, BOYD, CYNTHIA MELINDA · 2019 to 2021
$2.2M
Patient-Centered Care for Older Adults with Multiple Chronic Conditions: Research and Mentoring ProgramK24AG056578 · NIA · JOHNS HOPKINS UNIVERSITY · PI BOYD, CYNTHIA MELINDA · 2017 to 2021
$1.1M
Bladder Antimuscarinics in Dementia: A Model of Decisions About Potentially Inappropriate MedicinesK23AG054742 · NIA · JOHNS HOPKINS UNIVERSITY · PI GREEN, ARIEL · 2017 to 2020
$795k
NIA NIH HHS K23 AG054742NIA NIH HHS K24 AG056578NIA NIH HHS R33 AG057289
6 · The paper itself

Abstract

Importance: Physicians endorse deprescribing of risky or unnecessary medications for older adults (aged ≥65 years) with dementia, but there is a lack of information on what influences decisions to deprescribe in this population. Objective: To understand how physicians make decisions to deprescribe for older adults with moderate dementia and ethical and pragmatic concerns influencing those decisions. Design, Setting, and Participants: A cross-sectional national mailed survey study of a random sample of 3000 primary care physicians from the American Medical Association Physician Masterfile who care for older adults was conducted from January 15 to December 31, 2021. Main Outcomes and Measures: The study randomized participants to consider 2 clinical scenarios in which a physician may decide to deprescribe a medication for older adults with moderate dementia: 1 in which the medication could cause an adverse drug event if continued and the other in which there is no evidence of benefit. Participants ranked 9 factors related to possible ethical and pragmatic concerns through best-worst scaling methods (from greatest barrier to smallest barrier to deprescribing). Conditional logit regression quantified the relative importance for each factor as a barrier to deprescribing. Results: A total of 890 physicians (35.0%) returned surveys; 511 (57.4%) were male, and the mean (SD) years since graduation was 26.0 (11.7). Most physicians had a primary specialty in family practice (50.4% [449 of 890]) and internal medicine (43.5% [387 of 890]). A total of 689 surveys were sufficiently complete to analyze. In both clinical scenarios, the 2 greatest barriers to deprescribing were (1) the patient or family reporting symptomatic benefit from the medication (beneficence and autonomy) and (2) the medication having been prescribed by another physician (autonomy and nonmaleficence). The least influential factor was ease of paying for the medication (justice). Conclusions and Relevance: Findings from this national survey study of primary care physicians suggests that understanding ethical aspects of physician decision-making can inform clinician education about medication management and deprescribing decisions for older adults with moderate dementia.

Indexed as

DementiaDeprescriptionsPhysiciansAgedCross-Sectional StudiesFemaleHumansMaleUnited States

Identifiers

PMID37787993
PMCPMC10548310
OpenAlexW4387296324

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.